Erythropoiesis-stimulating agents in anemia

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Erythropoietin, a humoral factor produced predominantly in the kidney, stimulates red blood cell production in the bone marrow. Erythropoiesis- stimulating agents (ESAs) have been used for years in the treatment of anemia, with extensive experience and benefits in anemia of chronic kidney disease. Recent data have suggested adverse consequences with use of ESAs, perhaps relating to inappropriate use, and prompting release of guidelines to ensure safe use and maximize benefit. When prescribing ESAs, indications, requirements to monitor laboratory parameters (hemoglobin levels and ferrokinetics), and clinical status need to be stringently followed.

Original languageEnglish (US)
JournalGeriatrics
Volume63
Issue number6
StatePublished - Jun 2008
Externally publishedYes

Fingerprint

Hematinics
Anemia
Erythropoietin
Chronic Renal Insufficiency
Hemoglobins
Erythrocytes
Bone Marrow
Guidelines
Kidney

Keywords

  • Anemia
  • Chronic kidney disease
  • Erythropoietin
  • Hemoglobin
  • Older adults

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Erythropoiesis-stimulating agents in anemia. / Dharmarajan, Thiruvinvamalai S.; Widjaja, David.

In: Geriatrics, Vol. 63, No. 6, 06.2008.

Research output: Contribution to journalArticle

@article{e6d398c779c34c769930988ac8b604ca,
title = "Erythropoiesis-stimulating agents in anemia",
abstract = "Erythropoietin, a humoral factor produced predominantly in the kidney, stimulates red blood cell production in the bone marrow. Erythropoiesis- stimulating agents (ESAs) have been used for years in the treatment of anemia, with extensive experience and benefits in anemia of chronic kidney disease. Recent data have suggested adverse consequences with use of ESAs, perhaps relating to inappropriate use, and prompting release of guidelines to ensure safe use and maximize benefit. When prescribing ESAs, indications, requirements to monitor laboratory parameters (hemoglobin levels and ferrokinetics), and clinical status need to be stringently followed.",
keywords = "Anemia, Chronic kidney disease, Erythropoietin, Hemoglobin, Older adults",
author = "Dharmarajan, {Thiruvinvamalai S.} and David Widjaja",
year = "2008",
month = "6",
language = "English (US)",
volume = "63",
journal = "Geriatrics",
issn = "0016-867X",
publisher = "Advanstar Communications",
number = "6",

}

TY - JOUR

T1 - Erythropoiesis-stimulating agents in anemia

AU - Dharmarajan, Thiruvinvamalai S.

AU - Widjaja, David

PY - 2008/6

Y1 - 2008/6

N2 - Erythropoietin, a humoral factor produced predominantly in the kidney, stimulates red blood cell production in the bone marrow. Erythropoiesis- stimulating agents (ESAs) have been used for years in the treatment of anemia, with extensive experience and benefits in anemia of chronic kidney disease. Recent data have suggested adverse consequences with use of ESAs, perhaps relating to inappropriate use, and prompting release of guidelines to ensure safe use and maximize benefit. When prescribing ESAs, indications, requirements to monitor laboratory parameters (hemoglobin levels and ferrokinetics), and clinical status need to be stringently followed.

AB - Erythropoietin, a humoral factor produced predominantly in the kidney, stimulates red blood cell production in the bone marrow. Erythropoiesis- stimulating agents (ESAs) have been used for years in the treatment of anemia, with extensive experience and benefits in anemia of chronic kidney disease. Recent data have suggested adverse consequences with use of ESAs, perhaps relating to inappropriate use, and prompting release of guidelines to ensure safe use and maximize benefit. When prescribing ESAs, indications, requirements to monitor laboratory parameters (hemoglobin levels and ferrokinetics), and clinical status need to be stringently followed.

KW - Anemia

KW - Chronic kidney disease

KW - Erythropoietin

KW - Hemoglobin

KW - Older adults

UR - http://www.scopus.com/inward/record.url?scp=47049112269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47049112269&partnerID=8YFLogxK

M3 - Article

VL - 63

JO - Geriatrics

JF - Geriatrics

SN - 0016-867X

IS - 6

ER -